Stock Watch: Pandemic Lessons For Smaller Commercial Biotechs
Neurocrine And Clovis Are Still Deep In Pandemic Pressures
Executive Summary
Recently launched branded drugs prescribed by specialist physicians and marketed by smaller commercial-stage biotech companies remain in the eye of the pandemic storm.